Lifecore Biomedical's (LFCR) Market Perform Rating Reaffirmed at William Blair

Lifecore Biomedical's (LFCR) Market Perform Rating Reaffirmed at William Blair

William Blair reiterated a "market perform" rating on shares of Lifecore Biomedical in a research report on Monday.

Lifecore Biomedical to be acquired by Webster Equity Partners (LFCR:NASDAQ)

Lifecore Biomedical (LFCR) to be acquired by Webster Equity for up to $663.7M, offering a 49.5%–130% premium and CVR.

Lifecore Biomedical (NASDAQ:LFCR) Stock Keeps Market Perform Rating at Barrington Research

Lifecore Biomedical (NASDAQ:LFCR – Get Free Report)‘s stock had its “market perform” rating restated by Barrington Research in a research report issued on Tuesday, Benzinga reports. LFCR has been the topic of several other reports. Weiss Ratings upgraded shares of Lifecore Biomedical from a “sell (e+)” rating to a “sell (d-)” rating in a report […]

Lifecore Biomedical (Nasdaq: LFCR) Closes up on Acquisition News

Lifecore Biomedical (Nasdaq: LFCR) closed up 55.24% at $6.52 on news it will be acquired by Webster Equity Partners for up to $663.7 million.